Sarah H. Taylor, Kelly W. Merriman, Philippe E. Spiess and Louis Pisters Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer Cancer 106
Article first published online: 20 DEC 2005 | DOI: 10.1002/cncr.21605
In this study, the authors determined that, in its current format, patients with American Joint Committee on Cancer (AJCC) Stage IV prostate cancer did not represent a homogenous group. The results indicated that the AJCC staging system should be revised to reflect the important differences between patients with positive regional lymph node involvement and patients with distant metastasis.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.